Drug intelligence / Profile preview

capsicum oleoresin + naproxen

Development stage
Approved
Lead developer
ScieGen Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

A combination pharmaceutical product containing **capsicum oleoresin** (topical capsaicin) and **naproxen** (oral NSAID), primarily supplied as a co-packaged kit (tablet and cream) for the **temporary relief of minor aches and pains of muscles and joints** such as those associated with arthritis, tendonitis, bursitis, sprains, and strains. **Naproxen** is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing prostaglandin synthesis to provide anti-inflammatory, analgesic, and antipyretic effects. **Capsicum oleoresin** contains capsaicin, which is a selective agonist of the TRPV1 receptor in cutaneous sensory neurons; it produces local desensitization of pain fibers through prolonged receptor activation and local depletion of substance P, resulting in analgesia. This combination leverages systemic and local mechanisms to improve pain control[1][2][4][6][7].

Brand names
Naprotin
Other names
naproxen/capsaicin kitnaproxen and capsaicin kit
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on capsicum oleoresin + naproxen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on capsicum oleoresin + naproxen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call